CNE100004S13
CNE100004S13
ACROBIOSYSTEMS
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 838.117.619 | 645.021.891 | 29.9% |
| Cost of Revenue | 74.128.766 | 58.485.173 | 26.7% |
| Gross Profit | 763.988.853 | 586.536.718 | 30.3% |
| 567.030.197 | 477.219.984 | 18.8% | |
| Operating Income | 196.958.656 | 109.316.735 | 80.2% |
| Pretax Income | 169.323.109 | 124.914.740 | 35.6% |
| Net Income Common Stockholders | 165.567.565 | 123.832.480 | 33.7% |
| -- | -- | -- | |
| -- | -- | -- |